Cross Country Healthcare Statistics
Total Valuation
CCRN has a market cap or net worth of $424.39 million. The enterprise value is $320.84 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CCRN has 32.20 million shares outstanding. The number of shares has decreased by -2.10% in one year.
| Current Share Class | 32.20M |
| Shares Outstanding | 32.20M |
| Shares Change (YoY) | -2.10% |
| Shares Change (QoQ) | -2.67% |
| Owned by Insiders (%) | 7.89% |
| Owned by Institutions (%) | 83.49% |
| Float | 29.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 78.59 |
| PS Ratio | 0.42 |
| Forward PS | 0.42 |
| PB Ratio | 1.33 |
| P/TBV Ratio | 2.04 |
| P/FCF Ratio | 10.83 |
| P/OCF Ratio | 8.97 |
| PEG Ratio | 7.86 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 22.73, with an EV/FCF ratio of 8.19.
| EV / Earnings | n/a |
| EV / Sales | 0.32 |
| EV / EBITDA | 22.73 |
| EV / EBIT | n/a |
| EV / FCF | 8.19 |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.29 |
| Quick Ratio | 3.20 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.05 |
| Interest Coverage | -0.35 |
Financial Efficiency
Return on equity (ROE) is -26.98% and return on invested capital (ROIC) is -0.37%.
| Return on Equity (ROE) | -26.98% |
| Return on Assets (ROA) | -0.09% |
| Return on Invested Capital (ROIC) | -0.37% |
| Return on Capital Employed (ROCE) | -0.22% |
| Weighted Average Cost of Capital (WACC) | 6.59% |
| Revenue Per Employee | $126,989 |
| Profits Per Employee | -$12,500 |
| Employee Count | 7,890 |
| Asset Turnover | 1.95 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CCRN has paid $12.28 million in taxes.
| Income Tax | 12.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.77% in the last 52 weeks. The beta is 0.36, so CCRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -4.77% |
| 50-Day Moving Average | 9.83 |
| 200-Day Moving Average | 10.81 |
| Relative Strength Index (RSI) | 79.20 |
| Average Volume (20 Days) | 691,213 |
Short Selling Information
The latest short interest is 1.14 million, so 3.54% of the outstanding shares have been sold short.
| Short Interest | 1.14M |
| Short Previous Month | 1.27M |
| Short % of Shares Out | 3.54% |
| Short % of Float | 3.84% |
| Short Ratio (days to cover) | 2.92 |
Income Statement
In the last 12 months, CCRN had revenue of $1.00 billion and -$98.63 million in losses. Loss per share was -$3.07.
| Revenue | 1.00B |
| Gross Profit | 202.50M |
| Operating Income | -778,000 |
| Pretax Income | -86.35M |
| Net Income | -98.63M |
| EBITDA | 14.11M |
| EBIT | -778,000 |
| Loss Per Share | -$3.07 |
Full Income Statement Balance Sheet
The company has $105.58 million in cash and $2.04 million in debt, with a net cash position of $103.54 million or $3.22 per share.
| Cash & Cash Equivalents | 105.58M |
| Total Debt | 2.04M |
| Net Cash | 103.54M |
| Net Cash Per Share | $3.22 |
| Equity (Book Value) | 312.81M |
| Book Value Per Share | 9.94 |
| Working Capital | 207.73M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $47.34 million and capital expenditures -$8.16 million, giving a free cash flow of $39.18 million.
| Operating Cash Flow | 47.34M |
| Capital Expenditures | -8.16M |
| Depreciation & Amortization | 14.89M |
| Net Borrowing | n/a |
| Free Cash Flow | 39.18M |
| FCF Per Share | $1.22 |
Full Cash Flow Statement Margins
Gross margin is 20.21%, with operating and profit margins of -0.08% and -9.84%.
| Gross Margin | 20.21% |
| Operating Margin | -0.08% |
| Pretax Margin | -8.62% |
| Profit Margin | -9.84% |
| EBITDA Margin | 1.41% |
| EBIT Margin | -0.08% |
| FCF Margin | 3.91% |
Dividends & Yields
CCRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.10% |
| Shareholder Yield | 2.10% |
| Earnings Yield | -23.24% |
| FCF Yield | 9.23% |
Analyst Forecast
The average price target for CCRN is $13.62, which is 3.34% higher than the current price. The consensus rating is "Hold".
| Price Target | $13.62 |
| Price Target Difference | 3.34% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 2.88% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CCRN has an Altman Z-Score of 4.8 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.8 |
| Piotroski F-Score | 3 |